Most Recent Articles by Namir Khandker, MD
Recent research found benefits in outcome outweighed any increase in hemorrhagic complications in patients with large infarcts.
Although the study did not demonstrate efficacy of glyburide, differences were seen in the amount midline shift at 3-4 days.
The greatest hurdle in developing effective treatments for TBI lies in the varied and dynamic pathophysiology and incomplete understanding of factors leading to poor outcome.
Despite 3 large randomized trials and updated guidelines, the question of PFO closure remains a complex entity.
A joint medical and surgical approach may ensure the best outcome.
More Articles by Namir Khandker, MD
Neurology Advisor Articles
- Cannabis: Current Evidence and Research Recommendations
- Addressing Gender Differences in Concussion Diagnosis and Treatment
- Relapsing-Remitting Multiple Sclerosis Halted With Immunosuppression, Stem Cell Transplant
- Maternal Antiepileptic Use and Risk for Major Congenital Malformations in Offspring
- In Stroke, No Clear Benefit for Head Positioning